Thompson Davis & Co
TEVA icon

Thompson Davis & Co’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Thompson Davis & Co’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$559K Buy
14,125
+3,225
+30% +$115K 0.38% 56
2026
Q2 		$369K Buy
10,900
+500
+5% +$16.7K 0.22% 88
2026
Q1 		$313K Hold
10,400
– – 0.21% 80
2025
Q4 		$325K Hold
10,400
– – 0.19% 91
2025
Q3 		$210K Buy
+10,400
New +$183K 0.13% 119
2017
Q1 		– Sell
-271
Closed -$10K – 1230
2016
Q4 		$10K Hold
271
– – 0.02% 707
2016
Q3 		$12K Hold
271
– – 0.02% 626
2016
Q2 		$14K Hold
271
– – 0.02% 564
2016
Q1 		$15K Buy
271
+34
+14% +$2K 0.02% 542
2015
Q4 		$16K Sell
237
-112
-32% -$6.92K 0.02% 532
2015
Q3 		$20K Buy
349
+47
+16% +$3.05K 0.03% 469
2015
Q2 		$18K Hold
302
– – 0.02% 575
2015
Q1 		$19K Sell
302
-121
-29% -$7.04K 0.02% 545
2014
Q4 		$24K Buy
423
+61
+17% +$3.4K 0.03% 466
2014
Q3 		$19K Buy
+362
New +$19.2K 0.02% 483

Other funds holding TEVA

Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $313B AUM 26.62% 1-Year Est. Return
Phoenix Financial
Phoenix Financial Givatayim, Israel $14.8B AUM 42.86% 1-Year Est. Return
Migdal Insurance & Financial Holdings
Migdal Insurance & Financial Holdings Petach Tikva, Israel $16.3B AUM 54.64% 1-Year Est. Return
Harel Insurance Investments & Financial Services
Harel Insurance Investments & Financial Services Ramat Gan, Israel $21.3B AUM 44.31% 1-Year Est. Return
Lingotto Investment Management
Lingotto Investment Management London, United Kingdom $5.74B AUM 42.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Y.D. More Investments
Y.D. More Investments Ramat Gan, Israel $3.47B AUM 82.09% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.8B AUM 33.92% 1-Year Est. Return
Bessemer Group
Bessemer Group Woodbridge, New Jersey $72.8B AUM 32.97% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Thompson Davis & Co's TEVA Position: Q3 2026 in Review

Thompson Davis & Co increased its Teva Pharmaceutical Industries Limited (TEVA) stake by 30% in Q3 2026, buying an estimated $115K and bringing the position to 14,125 shares worth $559K. The position accounts for 0.38% of the portfolio, ranked #56.

Thompson Davis & Co first reported a position in TEVA in Q3 2014 and has held it in 15 quarters since. 288 funds tracked by Wall St. Rank hold TEVA as of Q3 2026.

  • Thompson Davis & Co held 14,125 shares of Teva Pharmaceutical Industries Limited worth $559K as of Q3 2026.
  • Thompson Davis & Co bought 3,225 Teva Pharmaceutical Industries Limited shares in Q3 2026, an estimated $115K.
  • Teva Pharmaceutical Industries Limited made up 0.38% of Thompson Davis & Co's portfolio in Q3 2026, its #56 holding.
  • Thompson Davis & Co first reported a position in Teva Pharmaceutical Industries Limited in Q3 2014 and has held it in 15 quarters since.
  • 288 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q3 2026.

Based on Thompson Davis & Co's 13F filing for Q3 2026, filed 5 Nov 2026.